| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/16/2009 | US20090098126 Method and kit for the detection of adenoviruses |
| 04/16/2009 | US20090098123 Hcv coreceptor and methods of use thereof |
| 04/16/2009 | US20090098120 Compositions and methods for the treatment of immune related diseases |
| 04/16/2009 | US20090098119 Antidotes for factor xa inhibitors and methods of using the same |
| 04/16/2009 | US20090098117 Composition comprising and method of using angiopoietin-like protein 3 angptl3 |
| 04/16/2009 | US20090098106 PHARMACEUTICAL COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH NF-kB ACTIVITY |
| 04/16/2009 | US20090098099 Bacillus thuringiensis strains comprising novel crystal proteins which exhibit insecticidal activity against lepidopteran insects |
| 04/16/2009 | US20090098074 Keratin-Binding Effector Molecules Containing Reactive Dyes |
| 04/16/2009 | US20090098054 Methods and compositions relating to promoter regulation by muc1 and klf proteins |
| 04/16/2009 | US20090098053 La1 - the genome of a lactobacillus strain |
| 04/16/2009 | US20090098051 Bacillus thuringiensis toxin |
| 04/16/2009 | DE102007048432A1 A transglutaminase substrate which inhibits cysteine- and serine-protease and shows antibiotic properties, used e.g. for plant protection, treatment of infections and production of antibiotic film or surgical sponge |
| 04/16/2009 | CA2739719A1 Laminins, derivatives, and compositions including same and method for their therapeutic use |
| 04/16/2009 | CA2702400A1 Mite antigenic rice |
| 04/16/2009 | CA2702217A1 Modulation of sirp.alpha. - cd47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor |
| 04/16/2009 | CA2702212A1 Methods for assaying mc1r variants and mitochondrial markers in skin samples |
| 04/16/2009 | CA2702206A1 Methods of controlling plant seed and organ size |
| 04/16/2009 | CA2702024A1 Glucoamylase variants with altered properties |
| 04/16/2009 | CA2702019A1 Glucoamylase variants |
| 04/16/2009 | CA2701992A1 Process for producing mature recombinant mite group i allergen |
| 04/16/2009 | CA2701790A1 Humanized antibody |
| 04/16/2009 | CA2701705A1 Trimeric il-1ra |
| 04/16/2009 | CA2701369A1 Modified growth hormone polypeptides |
| 04/16/2009 | CA2701362A1 Soluble fragments of influenza virus pb2 protein capable of binding rna-cap |
| 04/15/2009 | EP2048506A1 Postprandial hyperglycemia marker, method for determination thereof, and use thereof |
| 04/15/2009 | EP2048505A2 Method for early recognition of the seroconversion of an antibody to hepatitis C |
| 04/15/2009 | EP2048503A1 Assay for monitoring activity of frizzled receptors |
| 04/15/2009 | EP2048237A1 Replication deficient Influenza virus for the expression of heterologous sequences |
| 04/15/2009 | EP2048234A1 Chromatographic method for purification of albumin |
| 04/15/2009 | EP2048160A1 Tumor antigen based on products of the tumor suppressor gene WT1 |
| 04/15/2009 | EP2048159A1 T cell receptor display |
| 04/15/2009 | EP2048158A1 Glycosylated human alpha interferon muteins, method for obtaining them and use |
| 04/15/2009 | EP2048157A1 Polynucleotide encoding the rg1 polypeptide |
| 04/15/2009 | EP2048156A1 Process for providing a temperature-stable muscle relaxant on the basis of the neurotoxic component of botulinum toxin |
| 04/15/2009 | EP2048155A1 Method and means for the production of pharmaceutically active natural products |
| 04/15/2009 | EP2047866A1 Bonding tissues and cross-linking proteins with naphthalimide compounds |
| 04/15/2009 | EP2047861A1 Lentiviral gene transfer vectors suitable for iterative administration and their medicinal applications |
| 04/15/2009 | EP2047263A2 Compositions and methods for diagnosing patients with acute atherosclerotic syndromes |
| 04/15/2009 | EP2047260A2 Enabling methods to identify allosteric modulators of receptor activity |
| 04/15/2009 | EP2047252A1 Structure of the insulin receptor ectodomain |
| 04/15/2009 | EP2046965A2 Knockout mice for different genes and their use for gene characterization |
| 04/15/2009 | EP2046960A1 Process for producing arachidonic acid and/or eicosapentaenoic acid in plants |
| 04/15/2009 | EP2046959A1 Polynucleotides and methods for enhancing salinity tolerance in plants |
| 04/15/2009 | EP2046958A1 Cleavage of bip by subtilase cytotoxin |
| 04/15/2009 | EP2046943A1 Lactic acid bacteria isolated from mother's milk with probiotic activity and inhibitory activity against body weight augmentation |
| 04/15/2009 | EP2046830A1 Csf3r polypeptides and uses thereof |
| 04/15/2009 | EP2046829A2 Model taste cells and methods of use for identifying modulators of taste sensation |
| 04/15/2009 | EP2046828A2 Nogo receptor functional motifs, peptide mimetics, and mutated functional motifs related thereto, and methods of using the same |
| 04/15/2009 | EP2046826A2 Exendin fusion proteins |
| 04/15/2009 | EP2046825A1 Antimicrobial peptide derived from galanin message associated peptide (gmap) |
| 04/15/2009 | EP2046824A1 Novel compounds and their effects on feeding behaviour |
| 04/15/2009 | EP2046823A1 Post-translationally modified neurotrophins |
| 04/15/2009 | EP2046822A1 Molecular probe for sphingolipids |
| 04/15/2009 | EP2046821A1 Fusion peptide for inhibiting interaction of neuronal nmda receptor (nmdar) and nmdar interacting proteins |
| 04/15/2009 | EP2046820A2 Muteins of tear lipocalin and methods for obtaining the same |
| 04/15/2009 | EP2046818A2 Method of selective protein enrichment and associated applications |
| 04/15/2009 | EP2046817A1 Improved process for the preparation of copolymer-1 |
| 04/15/2009 | EP2046816A1 Cysteine-tagged staphylococcal protein g variant |
| 04/15/2009 | EP2046814A2 Minimized small peptides with high affinity for factor viii and factor viii-like proteins |
| 04/15/2009 | EP2046812A1 A cancer vaccine comprising a mucin 1 (muc1) t cell epitope-derived peptide |
| 04/15/2009 | EP2046811A2 Novel polypeptides |
| 04/15/2009 | EP2046810A2 Method of covalently linking a carbohydrate or polyalkylene oxide to a peptide, precursors for use in the method and resultant products. |
| 04/15/2009 | EP2046809A2 Wsx-1/p28 as a target for anti-inflammatory responses |
| 04/15/2009 | EP2046394A2 Use of nucleic acid sequences for the treatment of neurological and psychiatric diseases, vectors and compositions |
| 04/15/2009 | EP2046379A2 Immunogenic proteins of burkholderia pseudomallei and uses thereof |
| 04/15/2009 | EP2046111A2 Plants with enhanced size and growth rate |
| 04/15/2009 | EP2046109A2 Photosyntheticorganisms and compositions and methods of generating same |
| 04/15/2009 | EP2005174A4 Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory |
| 04/15/2009 | EP1817056A4 Parathyroid hormone receptor activation and stem and progenitor cell expansion |
| 04/15/2009 | EP1753778B1 Method for purifying erythropoietin |
| 04/15/2009 | EP1710250B1 Method for preparing human serum albumin through heat-treatment in presence of divalent cation |
| 04/15/2009 | EP1654284B1 Process for preparing an alpha-1-antitrypsin solution |
| 04/15/2009 | EP1629007B1 Novel peptides that bind to the erythropoietin receptor |
| 04/15/2009 | EP1546185B1 Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof |
| 04/15/2009 | EP1534844B1 Method for improving corn starch extractability |
| 04/15/2009 | EP1483394B1 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 04/15/2009 | EP1458677B1 3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of ppar-alpha |
| 04/15/2009 | EP1383796B1 Neurovirulent strain of the west nile virus and applications thereof |
| 04/15/2009 | EP1373506B1 Yeast strain of saccharomyces cerevisiae with functional expression of a glut transporter |
| 04/15/2009 | EP1334196B1 Genomic fragment of streptococcus suis and clinical uses thereof |
| 04/15/2009 | EP1325145B1 Adenoviral vectors for gene delivery in skeletal muscle cells or myoblasts |
| 04/15/2009 | EP1257295B1 Factor vii or viia-like molecules |
| 04/15/2009 | EP1255852B9 Immunoassay and diagnostic reagent for malaria |
| 04/15/2009 | EP1161452B1 Covalently bridged insulin dimers |
| 04/15/2009 | EP0792292B2 Estrogen receptor |
| 04/15/2009 | CN101410529A Method for producing an interleukin-2 preparation and the thus obtainable preparation |
| 04/15/2009 | CN101410519A Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
| 04/15/2009 | CN101410411A RAGE fusion proteins and methods of use |
| 04/15/2009 | CN101410410A Process for preparing human G-CSF |
| 04/15/2009 | CN101410409A Immunomodulating composition |
| 04/15/2009 | CN101408546A Method of detecting autoantibodies from patients suffering from rheumatoid arthritis, a peptide and an assaykit |
| 04/15/2009 | CN101407812A Heterologous expression and purification method for human RANTES protein having chemotaxis |
| 04/15/2009 | CN101407543A Labelled glutamine and lysine analogues |
| 04/15/2009 | CN101407542A Preparations and uses of streptomycin-carrier protein coupled product and streptomycin antibody |
| 04/15/2009 | CN101406696A Vaccine comprising a tick cement protein |
| 04/15/2009 | CN101406692A Vaccine composition containing transforming growth factor alpha |
| 04/15/2009 | CN100478689C Polypeptide and use thereof |
| 04/15/2009 | CN100478359C Polyethylene glycol-interferon coupler and its preparation method |
| 04/15/2009 | CN100478357C Ofloxacin couple and its preparing method and use |
| 04/15/2009 | CN100478356C SPG3A gene mutation, encoded production, and application |